First experiences with the Flexivue Microlens corneal inlay for presbyopia treatment

Session Details

Session Title: Presented Poster Session: Refractive Surgery New Techniques/Instrumentation/Devices III

Venue: Poster Village: Pod 2

First Author: : R.Khoramnia GERMANY

Co Author(s): :    F. Hengerer   G. Auffarth                    

Abstract Details

Purpose:

To evaluate the visual and refractive outcomes after implantation of an intracorneal inlay (Flexivue, Microlens, Presbia, Inc.) as a refractive lens for presbyopia treatment.

Setting:

International Vision Correction Research Centre (IVCRC), University Eye Clinic Heidelberg, Heidelberg, Germany

Methods:

So far, ten patients with a median age of 51 years (range: 44 – 65 years) were evaluated and followed up for 2-6 months in this ongoing clinical study. The inlay was inserted via an instrastromal pocket created with a femtosecond-laser (WaveLight FS200, Alcon, USA) at a corneal depth of 300 µm. The inlay was monocularly placed in the near-dominant eye after preoperative contact lens testing. Amongst others, uncorrected near visual acuity (UNVA) and uncorrected distance visual acuity (UDVA) were tested monocularly as well as binocularly.

Results:

The median preoperative spherical equivalent was +0.5 D (range: -0.4 to +1.1 D). Median preoperative UNVA of the operated eye was 0.60 logMAR (range: 0.92 to 0.2 logMAR) and median postoperative UNVA 0.1 logMAR (range: 0.30 to -0.14 logMAR). Median postoperative UDVA was 0.3 logMAR in the operated eye monocularly and 0.0 logMAR binocularly.

Conclusions:

The Presbia Microlens Corneal Inlay provides excellent uncorrected near visual acuity results. At the same time, binocular distance visual acuity is preserved. Preoperative contact lens testing for tolerance of modified monovision is important to identify suitable candidates.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company